SCHEMBL25539141

SCHEMBL25539141

CC1(C)c2cccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)n4)c4ccccc34)c2-c2ccc3ccccc3c21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.32
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 3/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
MEN1 O00255 2/20 0.31
LMNA P02545 2/20 0.31
KMT2A Q03164 2/20 0.31
GLA P06280 1/20 0.31
PDK2 Q15119 1/20 0.30
PSD A5PKW4 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CHRNA1 P02708 1/20 0.30
CHRNG P07510 1/20 0.30
CHRNB1 P11230 1/20 0.30
CHRNB2 P17787 1/20 0.30
SLC6A2 P23975 1/20 0.30
CHRNB4 P30926 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539143 0.96 ALDH1A1 (0.32) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25536728 0.93 MEN1 (0.32) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25539145 0.92 KDM4E (0.32) ALDH1A1KDM4EMAPTHPGDPSD
SCHEMBL25539622 0.91 PIM1 (0.31) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25539140 0.91 CHRNA1 (0.32) ALDH1A1KDM4EMAPTHPGDCHRNA1
SCHEMBL25539826 0.91 PDK2 (0.34) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25539126 0.90 PIM1 (0.32) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25534265 0.90 MEN1 (0.33) ALDH1A1KDM4EMAPTHPGDMEN1
SCHEMBL25539119 0.90 CYP1A1 (0.34) PIM1ALDH1A1KDM4EMAPTHPGD
SCHEMBL25539074 0.90 HPGD (0.35) PIM1ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885ALDH1A1 254/4885KDM4E 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.